Arrowhead adds newest facility to its Midwest hub in RNAi drug production push

Arrowhead Pharmaceuticals has purchased 13 acres of land in Wisconsin’s Verona Technology Park and will build a 140,000-square-foot drug manufacturing facility.

The company will spend between $200 million and $250 million to build out the facilities, and the site is expected to create another 250 jobs for the region. Construction...

Click to view original post